Search
for
Sort by
Research 211–240 of 1000+
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- The Relationship Between ABO And Rh Blood Groups With Alopecia Areata
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Not just thinning: A case of alopecia universalis after mild COVID-19
- The effect of latanoprost 0.005% solution in the management of scalp alopecia areata, a randomized double‐blind placebo‐controlled trial
- Determination of serum 25-hydroxyvitamin D levels in patients with alopecia areata and their comparison with levels in healthy controls: A cross-sectional study
- Time to loss of response for dupilumab in ophiasis-pattern alopecia areata
- Cellular retinol‐binding protein‐1 expression increases with increasing clinical severity of alopecia areata
- Reply to: “Serum vitamin D level and disease severity of alopecia areata: A meta-regression analysis”
- A clinical study on alopecia areata
- Etiopathogenesis of Alopecia Areata
- Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority
- Assessment of Alopecia Areata Disease Severity in Pediatric Patients
- Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Society of Dermatology. Part 2: Treatment
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis
- Safety and efficacy of microneedling with autologous platelet-rich plasma in chronic and stable alopecia areata
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Dermoscopic Analysis of Patients with and without Poor Prognostic Indicators in Alopecia Areata – A Comparative Study
- Alopecia Areata in Skin of Color: Trichoscopic Analysis in Black/African American Patients
- 723 - Efficacy of ritlecitinib in patients with alopecia areata by extent of hair loss at baseline: post hoc analysis of the phase 3 long-term ALLEGRO-LT study
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study
- Excimer Light versus Combination of Tacrolimus and Excimer Light in the Treatment of Alopecia Areata
- Serum Epidermal Growth Factor Level and its Relation to Severity of Alopecia Areata
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2